NEA Management Company as of Sept. 30, 2021
Portfolio Holdings for NEA Management Company
NEA Management Company holds 63 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Robinhood Mkts Com Cl A (HOOD) | 37.4 | $3.1B | 75M | 42.08 | |
| Bright Health Group | 21.2 | $1.8B | 218M | 8.16 | |
| Coursera (COUR) | 6.0 | $502M | 16M | 31.65 | |
| CVRX (CVRX) | 4.7 | $392M | 2.4M | 165.40 | |
| Berkshire Grey Com Cl A | 3.2 | $269M | 38M | 7.03 | |
| Allakos (ALLK) | 2.7 | $229M | 2.2M | 105.87 | |
| Crispr Therapeutics Namen Akt (CRSP) | 2.1 | $178M | 1.6M | 111.93 | |
| Monte Rosa Therapeutics (GLUE) | 2.0 | $172M | 7.7M | 22.28 | |
| Bill Com Holdings Ord (BILL) | 1.8 | $150M | 561k | 266.95 | |
| Aurinia Pharmaceuticals (AUPH) | 1.4 | $115M | 5.2M | 22.13 | |
| Trillium Therapeutics Com New | 1.2 | $101M | 5.7M | 17.56 | |
| Cloudflare Cl A Com (NET) | 1.2 | $100M | 890k | 112.65 | |
| Adaptimmune Therapeutics Adr (ADAP) | 1.0 | $88M | 17M | 5.17 | |
| Mirum Pharmaceuticals (MIRM) | 1.0 | $83M | 4.2M | 19.92 | |
| Nkarta (NKTX) | 1.0 | $81M | 2.9M | 27.81 | |
| Oyster Point Pharma | 0.8 | $70M | 5.9M | 11.85 | |
| Rhythm Pharmaceuticals (RYTM) | 0.8 | $64M | 4.9M | 13.06 | |
| Vectivbio Hldg Ord Shs | 0.6 | $52M | 67k | 772.50 | |
| Akouos | 0.6 | $50M | 4.3M | 11.61 | |
| Vistagen Therapeutics | 0.5 | $45M | 16M | 2.74 | |
| Annexon (ANNX) | 0.5 | $44M | 2.4M | 18.61 | |
| Reneo Pharmaceuticals (RPHM) | 0.4 | $36M | 4.8M | 7.45 | |
| Galera Therapeutics (GRTX) | 0.4 | $35M | 4.4M | 8.10 | |
| Metromile | 0.4 | $33M | 9.4M | 3.55 | |
| Savara (SVRA) | 0.4 | $33M | 24M | 1.38 | |
| Eargo | 0.4 | $30M | 4.5M | 6.73 | |
| Black Diamond Therapeutics (BDTX) | 0.3 | $29M | 3.4M | 8.46 | |
| Inozyme Pharma (INZY) | 0.3 | $28M | 2.4M | 11.59 | |
| Verona Pharma Ads (VRNA) | 0.3 | $28M | 5.1M | 5.47 | |
| Affimed Therapeutics B V | 0.3 | $27M | 4.4M | 6.18 | |
| Casper Sleep | 0.3 | $27M | 6.2M | 4.27 | |
| Bloom Energy Corp Com Cl A (BE) | 0.3 | $25M | 1.3M | 18.72 | |
| Aveo Pharmaceuticals | 0.3 | $24M | 4.0M | 6.18 | |
| Mei Pharma Com New | 0.3 | $24M | 8.5M | 2.76 | |
| Cti Biopharma Corp Com New | 0.3 | $21M | 7.1M | 2.95 | |
| Phasebio Pharmaceuticals | 0.2 | $21M | 6.6M | 3.11 | |
| Genocea Biosciences (GNCAQ) | 0.2 | $20M | 10M | 1.92 | |
| Glycomimetics (GLYC) | 0.2 | $20M | 9.1M | 2.19 | |
| Geron Corporation (GERN) | 0.2 | $18M | 14M | 1.37 | |
| Inventiva Sa Ads (IVA) | 0.2 | $18M | 1.3M | 14.16 | |
| Marker Therapeutics Ord | 0.2 | $18M | 11M | 1.69 | |
| Ardelyx (ARDX) | 0.2 | $18M | 14M | 1.32 | |
| Champions Oncology Com New (CSBR) | 0.2 | $18M | 1.7M | 10.21 | |
| Imara | 0.2 | $16M | 4.0M | 4.08 | |
| Xenon Pharmaceuticals (XENE) | 0.2 | $15M | 992k | 15.28 | |
| Satsuma Pharmaceuticals Ord | 0.2 | $15M | 3.1M | 4.66 | |
| Obseva Sa | 0.2 | $14M | 4.6M | 3.11 | |
| Synlogic | 0.2 | $13M | 4.2M | 3.05 | |
| Lexicon Pharmaceuticals Com New (LXRX) | 0.1 | $12M | 2.4M | 4.81 | |
| Metacrine Ord | 0.1 | $11M | 3.1M | 3.43 | |
| Desktop Metal Com Cl A | 0.1 | $10M | 14M | 0.72 | |
| Strongbridge Biopharma Shs Usd | 0.1 | $8.4M | 4.1M | 2.04 | |
| Trevi Therapeutics (TRVI) | 0.1 | $8.3M | 5.9M | 1.40 | |
| Liquidia Technologies (LQDA) | 0.1 | $6.9M | 2.5M | 2.76 | |
| Lumos Pharma (LUMO) | 0.1 | $5.0M | 527k | 9.51 | |
| Trevena | 0.1 | $4.7M | 3.8M | 1.23 | |
| Regulus Therapeutics Com New | 0.1 | $4.5M | 6.5M | 0.69 | |
| Erytech Pharma Sa Adr | 0.0 | $3.6M | 625k | 5.77 | |
| Tempest Therapeutics (TPST) | 0.0 | $1.7M | 118k | 14.47 | |
| Addex Therapeutics Sponsored Ads | 0.0 | $1.6M | 180k | 9.01 | |
| Tracon Pharmaceuticals | 0.0 | $1.3M | 347k | 3.87 | |
| Akari Therapeutics Adr | 0.0 | $737k | 452k | 1.63 | |
| Viracta Therapeutics (VIRX) | 0.0 | $297k | 37k | 8.01 |
